Skip to main content

Vixa Skineal

Generic: Vixa Skineal Compound ketoconazole

Verified·Apr 23, 2026
Manufacturer
Kama Industries
NDC
84659-9040
Route
TOPICAL
ICD-10 indication
L30.9

Affordability Check

How much will you actually pay for Vixa Skineal?

In 30 seconds, see every legitimate way to afford Vixa Skineal — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Vixa Skineal

What is this medication? Vixa Skineal is a triple-action topical cream used to treat a wide variety of inflammatory skin disorders complicated by bacterial or fungal infections. It is a combination medication that typically contains ketoconazole, clobetasol propionate, and neomycin sulfate. These three active ingredients work together to address different aspects of skin irritation, providing relief from itching, redness, and swelling while simultaneously targeting the underlying cause of the infection. This medication is commonly prescribed for conditions such as tinea infections, including athlete's foot and ringworm, as well as various forms of dermatitis and eczema. The ketoconazole acts as an antifungal agent, the neomycin sulfate serves as an antibiotic to kill bacteria, and the clobetasol propionate is a potent corticosteroid that reduces inflammation. Because it contains a strong steroid and an antibiotic, it should only be used as directed by a healthcare professional to avoid skin thinning or antibiotic resistance.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Vixa Skineal. Official source: DailyMed (NLM) · Label effective Feb 5, 2025

Dosage and administration
DOSAGE AND ADMINISTRATION: Apply externally to affected area twice daily. It is suggested to use for 2 weeks on ordinary tinea corporis and tinea cruris, for 4 weeks on tinea pedis and tinea manus. SIDE EFFECTS: VIXA SKINEAL has few side effects when used topically. A few instance of irritation or burning sensation may be observed occasionally during the treatment. But usually, it is unnecessary to stop the drug. CONTRAINDICATION:

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.